Regentatlantic Capital LLC Astrazeneca PLC Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Regentatlantic Capital LLC holds 15,654 shares of AZN stock, worth $1.01 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

15,654

Previous 15,716 0.39%

Holding current value

$1.01 Million

Previous $1.04 Million 17.34%

% of portfolio

0.03%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $3,287 - $8,416	-62 Reduced 0.39%	15,654 $858,000
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $4,740 - $5,691	-80 Reduced 0.51%	15,716 $1.04 Million
Q1 2022 May 02, 2022	BUY	$55.72 - $67.12 $1,560 - $1,879	28 Added 0.18%	15,796 $1.05 Million
Q4 2021 Jan 27, 2022	BUY	$54.02 - $63.83 $41,379 - $48,893	766 Added 5.11%	15,768 $918,000
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $59,615 - $65,227	1,073 Added 7.7%	15,002 $901,000
Q2 2021 Aug 12, 2021	BUY	$48.42 - $60.18 $14,138 - $17,572	292 Added 2.14%	13,929 $834,000
Q1 2021 Apr 29, 2021	SELL	$47.16 - $54.44 $21,552 - $24,879	-457 Reduced 3.24%	13,637 $678,000
Q4 2020 Feb 04, 2021	BUY	$48.52 - $58.02 $13,343 - $15,955	275 Added 1.99%	14,094 $705,000
Q3 2020 Oct 13, 2020	SELL	$53.07 - $61.1 $7,960 - $9,165	-150 Reduced 1.07%	13,819 $757,000
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $8,189 - $10,508	190 Added 1.38%	13,969 $739,000
Q1 2020 May 14, 2020	SELL	$37.79 - $51.33 $5,744 - $7,802	-152 Reduced 1.09%	13,779 $615,000
Q4 2019 Feb 04, 2020	BUY	$42.46 - $50.46 $29,170 - $34,666	687 Added 5.19%	13,931 $695,000
Q3 2019 Oct 22, 2019	SELL	$40.12 - $45.47 $7,542 - $8,548	-188 Reduced 1.4%	13,244 $590,000
Q2 2019 Jul 23, 2019	SELL	$37.28 - $41.68 $17,447 - $19,506	-468 Reduced 3.37%	13,432 $554,000
Q1 2019 May 03, 2019	SELL	$35.49 - $43.02 $32,970 - $39,965	-929 Reduced 6.26%	13,900 $562,000
Q4 2018 Jan 30, 2019	SELL	$36.86 - $41.49 $28,013 - $31,532	-760 Reduced 4.88%	14,829 $563,000
Q3 2018 Oct 30, 2018	BUY	$34.76 - $39.72 $18,179 - $20,773	523 Added 3.47%	15,589 $617,000
Q2 2018 Jul 31, 2018	SELL	$34.55 - $37.05 $19,969 - $21,414	-578 Reduced 3.69%	15,066 $529,000
Q1 2018 Apr 23, 2018	SELL	$32.97 - $36.63 $857 - $952	-26 Reduced 0.17%	15,644 $547,000
Q4 2017 Jan 23, 2018	BUY	$32.09 - $34.78 $96 - $104	3 Added 0.02%	15,670 $544,000
Q3 2017 Oct 25, 2017	BUY	$28.96 - $34.0 $453,716 - $532,678	15,667	15,667 $531,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Astrazeneca PLC Transaction History